About Elixior

Elixior is an advisory company focused on the development and growth of innovative personalized medicine businesses.

Elixior's business activities are aimed at:

* Supporting the development and growth of personalized medicine businesses through the creation of partnerships and / or the sourcing of investments

* Helping personalized medicine companies with the structuring of their corporate and commercial strategies

* Conducting due diligence on personalized medicine ventures

* Building a world-wide, personalized medicine knowledge-base to support cooperation between personalized medicine businesses and the growth of the sector

Elixior is based in London (UK) and was established in 2009 by Dr. Anne Bruinvels, the founding entrepreneur of Curidium, a personalized medicine company focused on improving the diagnosis and treatment of central nervous system disorders. She was Curidium's CEO for more than six years, during which she took the company public on the AIM of the London Stock Exchange.